Real-world experience with long-term albumin in patients with cirrhosis and ascites

The ANSWER randomised-controlled trial has shown that long-term albumin treatment (LTA) is an effective approach for the management of patients with cirrhosis and ascites. This observational study provides novel information on target patients, modalities and length of treatment, predictors of ascites resolution, stopping criteria, and clinical trajectories of patients on treatment. LTA is a feasible option in the daily clinical practice for the management of ascites when given on top of diuretics. Rather than an alternative therapy, LTA should be integrated with the other treatment options already available for patients with difficult-to-treat ascites. The predictive factors of response identified in the present study can help physicians to individualise LTA and optimise the decision-making process.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2024-09-17
DOI
https://doi.org/10.1016/j.jhepr.2024.101221
Citations
10
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
3.69
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world experience with long-term albumin in patients with cirrhosis and ascites

Paolo Caraceni, Salvatore Piano, Paolo Angeli, Maurizio Baldassarre et al.
10 citations
JHEP Reports
Liver Disease and Transplantation
3.69
article

Real-world experience with long-term albumin in patients with cirrhosis and ascites

Paolo Caraceni, Salvatore Piano, Paolo Angeli, Maurizio Baldassarre, Stefania Gioia, Vincenza Calvaruso, Marta Tonon, Marco Domenicali, Giulia Iannone, Roberta Gagliardi, Clara De Venuto, Giorgio Bedogni, Giacomo Zaccherini, V. Di Marco, Antonio Lombardo, Pierluigi Toniutto, Enrico Pompili, Silvia Nardelli, Greta Tedesco, Davide Bitetto
article en
10 citations

Abstract

The ANSWER randomised-controlled trial has shown that long-term albumin treatment (LTA) is an effective approach for the management of patients with cirrhosis and ascites. This observational study provides novel information on target patients, modalities and length of treatment, predictors of ascites resolution, stopping criteria, and clinical trajectories of patients on treatment. LTA is a feasible option in the daily clinical practice for the management of ascites when given on top of diuretics. Rather than an alternative therapy, LTA should be integrated with the other treatment options already available for patients with difficult-to-treat ascites. The predictive factors of response identified in the present study can help physicians to individualise LTA and optimise the decision-making process.

JHEP ReportsVol. 6(12)
University of Udine (IT), University of Padua (IT), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Azienda USL di Bologna (IT), PromoFirenze (IT), Sapienza University of Rome (IT), University of Bologna (IT)
Zero hunger
Openalex Percentile: Top 6%
Liver Disease and Transplantation
3.69
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.